Literature DB >> 17138777

Glucose in vaginal secretions before and after oral glucose tolerance testing in women with and without recurrent vulvovaginal candidiasis.

Sophia Ehrström1, Anna Yu, Eva Rylander.   

Abstract

OBJECTIVE: To measure the change of glucose in vaginal secretions during glucose tolerance testing in women with recurrent vulvovaginal candidiasis and in healthy control subjects.
METHODS: Thirty-eight women with recurrent vulvovaginal candidiasis and 45 healthy, age-matched controls completed a health questionnaire regarding general and gynecologic health and food and alcohol habits. They all underwent an oral glucose tolerance test and a vaginal examination. Vaginal secretion was collected from the proximal part of the vagina. Glucose in plasma and in vaginal secretions were measured at fasting and after 2 hours and analyzed with the hexokinase method. A sample size analysis showed that the number of subjects included in the study was sufficient for a beta value of 0.80, at the significance level of alpha=.05, at a difference in glucose in vaginal secretions of 30% after oral glucose tolerance test.
RESULTS: In healthy women, the median level of glucose in vaginal secretions was 5.2 mM before and 3.7 mM after oral glucose tolerance test, and plasma glucose was 5.0 mM before and 5.8 mM after oral glucose tolerance test. No significant difference was seen regarding change of glucose level in vaginal secretions and plasma glucose after testing, compared with before oral glucose tolerance testing.
CONCLUSION: There were no differences between women with recurrent vulvovaginal candidiasis and control subjects regarding change in glucose level in vaginal secretions or in plasma during oral glucose tolerance test. LEVEL OF EVIDENCE: II-2.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17138777     DOI: 10.1097/01.AOG.0000246800.38892.fc

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  12 in total

1.  FDG uptake in vaginal tampons is caused by urinary contamination and related to tampon position.

Authors:  Irene A Burger; David A Scheiner; David W Crook; Valerie Treyer; Thomas F Hany; Gustav K von Schulthess
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-09-21       Impact factor: 9.236

2.  The Glycolytic Enzyme Triosephosphate Isomerase of Trichomonas vaginalis Is a Surface-Associated Protein Induced by Glucose That Functions as a Laminin- and Fibronectin-Binding Protein.

Authors:  Jesús F T Miranda-Ozuna; Mar S Hernández-García; Luis G Brieba; Claudia G Benítez-Cardoza; Jaime Ortega-López; Arturo González-Robles; Rossana Arroyo
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

3.  Glucose Mediates Niche-Specific Repression of Staphylococcus aureus Toxic Shock Syndrome Toxin-1 through the Activity of CcpA in the Vaginal Environment.

Authors:  Karine Dufresne; Vladyslav A Podskalniy; Christine A Herfst; Gabrielle F M Lovell; Isaac S Lee; Erica N DeJong; John K McCormick; Stephen W Tuffs
Journal:  J Bacteriol       Date:  2022-09-15       Impact factor: 3.476

4.  Characterization of the vaginal fungal flora in pregnant diabetic women by 18S rRNA sequencing.

Authors:  N-N Zheng; X-C Guo; W Lv; X-X Chen; G-F Feng
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-03-06       Impact factor: 3.267

5.  Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented.

Authors:  Sujit D Rathod; Patricia A Buffler
Journal:  BMC Womens Health       Date:  2014-03-10       Impact factor: 2.809

Review 6.  The Role of Fatty Acid Metabolites in Vaginal Health and Disease: Application to Candidiasis.

Authors:  Silke Baldewijns; Mart Sillen; Ilse Palmans; Paul Vandecruys; Patrick Van Dijck; Liesbeth Demuyser
Journal:  Front Microbiol       Date:  2021-07-02       Impact factor: 5.640

7.  Lamisil versus clotrimazole in the treatment of vulvovaginal candidiasis.

Authors:  Ali Zarei Mahmoudabadi; Mahin Najafyan; Eskandar Moghimipour; Maryam Alwanian; Zahra Seifi
Journal:  Iran J Microbiol       Date:  2013-03

8.  The Absence of N-Acetyl-D-glucosamine Causes Attenuation of Virulence of Candida albicans upon Interaction with Vaginal Epithelial Cells In Vitro.

Authors:  Máté Manczinger; Alexandra Bocsik; Gabriella F Kocsis; Andrea Vörös; Zoltán Hegedűs; Lilla Ördögh; Éva Kondorosi; Annamária Marton; Csaba Vízler; Vilmos Tubak; Mária Deli; Lajos Kemény; István Nagy; Lóránt Lakatos
Journal:  Biomed Res Int       Date:  2015-08-20       Impact factor: 3.411

9.  SNF3 as High Affinity Glucose Sensor and Its Function in Supporting the Viability of Candida glabrata under Glucose-Limited Environment.

Authors:  Tzu Shan Ng; Shu Yih Chew; Premmala Rangasamy; Mohd N Mohd Desa; Doblin Sandai; Pei Pei Chong; Leslie Thian Lung Than
Journal:  Front Microbiol       Date:  2015-12-01       Impact factor: 5.640

10.  Ketorolac-fluconazole: A New Combination Reverting Resistance in Candida albicans from Acute Myeloid Leukemia Patients on Induction Chemotherapy: In vitro Study.

Authors:  Shereen A Sayed; Ehsan A B Hassan; Muhamad R Abdel Hameed; Michael N Agban; Mostafa F Mohammed Saleh; Hayam H Mohammed; Abu-Baker M Abdel-Aal; Sherein G Elgendy
Journal:  J Blood Med       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.